Adverse effects of medicating hyperactive children by Jachowicz-Bloch, Mary
Cardinal Stritch University
Stritch Shares
Master's Theses, Capstones, and Projects
1-1-1978
Adverse effects of medicating hyperactive children
Mary Jachowicz-Bloch
Follow this and additional works at: https://digitalcommons.stritch.edu/etd
Part of the Special Education and Teaching Commons
This Research Paper is brought to you for free and open access by Stritch Shares. It has been accepted for inclusion in Master's Theses, Capstones, and
Projects by an authorized administrator of Stritch Shares. For more information, please contact smbagley@stritch.edu.
Recommended Citation
Jachowicz-Bloch, Mary, "Adverse effects of medicating hyperactive children" (1978). Master's Theses, Capstones, and Projects. 581.
https://digitalcommons.stritch.edu/etd/581
ADVERSE EFFECTS OF MEDICATING
 
HYPERACTIVE CHILDREN
 
by 
Mary Jachowicz-Bloch 
A RESEARCH PAPER
 
SUBMITTED IN PARTIAL FULFILLMENT OF THE
 
REQUIREMENTS FOR THE DEGREE OF
 
MASTER OF ARTS IN EDUCATION 
(EDUCATION OF LEARNING DISABLED CHILDREN) 
AT THE CARDINAL STRITCH COLLEGE 
Milwaukee, Wisconsin 
1978 
This research paper has been 
approved for the Graduate Committee 
of the Cardinal Stritch College by 
Date --"'~II'-""""""""""""'-----"""'-
ACKNOWLEDGMENTS 
This research paper is dedicated first and foremost 
to my parents who taught me that "I could do anything in 
this world I wanted to if I set my mind to it." Then to 
my husband who has given me freedom to pursue my interests. 
Finally, to my dear friends who have helped me in more 
ways than I could list. 
iii 
TABLE OF CONTENTS
 
Page 
ACKNOWLEDGMENTS. . . . . . . . . . . . . . . . . . iii
 
CHAPTER
 
I INTRODUCTION • . . • • • • . . . . . . 1
 
Statement of Purpose. • 1
 
Definition of Terms • • 2
 
Summary • • • • . • • • 2
 
II REVIEW OF THE LITERATURE • • 3
 
The Hyperactive Child • 3
 
Definition • • • • • • • • •
 3 
Etiology and Characteristics . . 8
 
The Drugs • • • . • • • • • • • 13
 
History of Medication. • • • • • •• 13
 
Diagnostic Criteria.. .• • 17
 
Pharmacologic Agents • • • • • • •• 28
 
Side Effects. • • • • • 48
 
Physical Effects • • • • • 4~
 
Emotional Effects. • • • 61
 
St1DIJD.ary. • • • • • • • • • . . . . . 67
 
III SUMMARY AND CONCLUSIONS. • • 68
 
St1DIJD.ary • • • 68
 
Conclusions 70
 
SELECTED BIBLIOGRAPHY.
 
• • • · 71 
CHAPTER I 
INTRODUCTION 
Statement of Purpose 
It is the purpose of this paper to review the 
literature showing the adverse affects of medicating the 
hyperactive child. The hyperactive child will be defined 
as well as causes given for the hyperactivity. A major 
focus presented is the use of drugs to treat the "medical tf 
problem of hyperactivity or minimal brain dysfunction. 
An historical perspective is introduced to indicate 
pharmacological agents currently at the disposal of the 
physician. 
The drug industry itself is explored in the dis­
cussion of the diagnostic evaluation and treatment. The 
physical and emotional detrimental effects of treating 
children with drugs is exposed. Questions alluded to in 
the conclusion suggest that all the factors that go into 
diagnosing and treating a child in a medical fashion may 
not bring about the desired effects. 
1 
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Definition of Terms 
Agranulocytosis--An acute dangerous condition in 
which there are too few white blood cells in the blood.! 
Anorexia--Want of appetite. 2 
Blood dyscrasia--A diseased condition of the system 
marked by general ill health and debility. 3 
Tachycardia--An unusual rapidity of the action 
of the heart. 4 
Summary 
A review of pertinent literature pertaining to the 
effects of medicating the hyperactive child will be review­
ed. Components used in defining who the child is and why 
the child is hyperactive will be explored. A background 
and expl.anation of drugs used will be given to show the 
physician's dilemma. An overall description of effects 
and definition of te~s is explained. What goes into the 
prescription of medication for a hyperactive child is the 
focus of this paper. 
INew Illustrated Medical Enc clo edia for Home Use, 
Robert E. Rot enbergt M.D., F.A.C.F., ed. New York: Abradale Press, 1967J, p. 1446. 
~ebster's New Twentieth Centur Dictionar (Cleve­
land/New York: The World Publishing Co., 1950 , p. 72. 
3Ibid., p. 540. 
4Ibid., p. 1738. 
CHAPTER II 
REVIE'" OF THE LITERATURE 
The Hyperactive Child 
Definition 
Advocates of the use of drugs fail to objectively 
define the distinction between no~al and abno~al behavior. 
Vonder Haar mentions that their concern is to charge 
• the disoriented child and the inept parent, the 
boring teacher, the' incompetent guardian. Parents and 
teachers advocating the use of amphetamines diagnose 
the condition and treat the condition with dangerous 
drugs without considering the possibility--indeed, the 
likelihood--that they, themselves, may be the cause. 
Is the child becoming the scapegoat for the social and 
psychological ills in certain families and classrooms? 
Must ne become a depository for all the neurotic re­
actions afflicti_g ~he adults around him? Will he become 
docile and obedient in order to escape being drugged?! 
Caution must be exerted in prescribing stimulant 
drugs because of their uncertain effects. Care must be 
exercised to avoid relying upon them as a panacea rather 
than an alternative in treatment. 
IT. A. Yonder Haar, "Chaining Children with Chemicals," 
The Progressive 39 (March 1975):16. 
3 
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Few treatment studies consider current ages or 
intelligence quotients, therefore, little within group 
variance is shown. 2 Although experimental studies have been 
well-controlled, the variables have not. Subject popula­
tions have been heterogeneous in clinical diagnosis, as well 
as reasons for referral for treatment, and types of learning 
difficulties. Studies often do not deal specifically with 
hyperkinetic children, nor agree on essential criteria for 
selection. In addition, rating instruments are not comparable. 
There is also contradictory evidence suggesting subject 
bias in diagnostic measures. 3 
Eisenberg claims that 
Psychometeric tests reveal normal intelligence, confirm 
the academic lag and sometimes display perceptual ab­
normalities. The diagnosis of -hyperkinetic syndrome 
is based upon the history and the symptom profile rather 
than upon special tests or examinations.4 
Because drugs are prescribed to control hyperactive 
children it becomes necessary for purposes of this paper, to 
2Susan P. Stephenson, M.B., Ch.B., F.R.C.P. (c.l "The 
Hyperkinetic Child: Some Misleading Assumptions." Canadian 
Medical Association Journal 113 (October 18, 1975):768. 
3Lester Grinspoon and Susan B. Singer, "Amphetamines 
in the Treatment of Hyperkinetic Children," Harvard Educa­
tional Review 43 (1973):525. 
4Leon Eisenberg, M.D., "Symposium: Behavior Modifica­
tion by Drugs--III. The Clinical Use of Stimulant Drugs in 
Children," Pediatrics 49 (May 1972):710. 
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use a single description which typifies hyperkinesis. 
Because medicine is used to treat the behaviors, a medical 
te~ is being explored as the physician bases his treatment 
on the recognition of this syndrome. A "syndrome" is 
generally how the physician refers to Multiple Brain Dys­
function (MBD) or hyperkinetic behavior. "The most prevalent 
belief is that hyperkinesis is either caused by or related 
to minimal cerebral dysfunction, ,,5 the terms used synony­
mously by Stephenson. Parents and teachers refer to it as 
"hyperactivity. ,,6 
M.B.D. is a description of children with borderline 
central nervous system impairment, often accompanied by 
problems of hyperactivity, learning deficits and motor 
disturbances. Not all symptoms need to be present 
simultaneously. They may be seen alone or in combination, 
with variations in degree of intensity and persistence over 
a period of time. Solomons writes, 
Lack of agreement complicates and often magnifies the 
problem, creating antagonism between the school which 
views the child's behavior as "disruptive," and the 
parents who believe their child is ,t all boy. tt The 
physician, often in the middle, finds nothing abno~al 
on examination and sides one way or the other, depending 
on how he is feeling that day or on the activity level 
of his own children. Medications may be prescribed on a 
5Stephenson, "The Hyperkinetic Child: Some Mis­
leading Assumptions," p. 768. 
6Lester Grinspooa M.D., and Peter Hedblom, "The 
Treatment of Hyperkinetic Children," The Speed Culture 
(1975):227. 
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trial-and-error basis with no planned dosage scale or 
appropriate followup.117 
When referring to M.B.D., Witter claims that ft ••• 
it must be recognized that drugs are a cheap alternative to 
the massive spending so obviously necessary to revitalize 
-the public school sys-tem. n8 In using -the -term M.B.D., 
the implications exist for ~ociety that the child is damaged 
and unable to learn, or that the child is disabled and UD-
controllable, depending on the orientation of their 
discipline. 
M.B.D., as a behavioral syndrome, is "defined by 
the subject's dissonance with the social environment," 
states Messinger, and to "ascribe the disequalibrium to 
brain damage is merely inference."9 The fac-t and concep-t 
of M.B.D. are for all intents and purposes the SaBe in 
solution to behaviors. He goes on to report that M.B.D. 
functions as a social designation more so than a medical 
diagnosis, that "it is hypothesis, not fact, that children 
10
who are overactive and inattentive have brain damage." 
7Gerald Solomons, M.D., "Child Hyperac-tivi-ty: Diagno­
sis, Treatment," Texas Medicine 63 (November 1967):52. 
8Charles Wi-t-ter, "Drugging and Schooling," Social 
Sciences and Modern Society 8 (July - August 1971):31. 
9Eli Messinger, "Ri-talin and M.B.D.," Heal-thLPAC 
Bulletin 67 (November/December 1975) :·5. 
lOIbid. 
The te~ M.B.D. is favored by Wender because it 
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implies no specific etiology, no pathognomonic signs and 
symptoms, no homogeneity of cause, course or trea~ment. 
Synonyms would include: hyperkinesis, hyperactivity, the 
hyperactive child syndrome, minimal brain damage, minimal 
cerebral dysfunction, specific learning disabilities and 
post encephalitic behavior disorder. ll 
The diagnosis is generally made in accordance with 
the child's history. The medical examination of the child 
himself is usually of little value. The disorder is chronic 
and may well last into puberty and beyond. 12 
A qualitative difference in the activity of the true 
M.B.D. from those who are simply restless or normally active 
is made by Messenger to the HEW panel on the use of stimulant 
drugs. The" ••• driven, inner tornado form of hyper­
activity is rare, and distractability is most often an 
expression of anxiety."1 3 Many clinicians assume that 
hyperactive behavior is a sign of brain da-age, the assump­
tion being that the absence of distinct neurological signs 
lipaul H. Wender, M.D., "The Minimal Brain Dysfunc­
tion Syndrome," Annual Review of Medicine 26 (1975):45. 
12Ibid • 
13Messinger, "Ritalin and M.B.D.," p. 9. 
I 
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only indicates minimal damage. Once classified, the child 
falls into a category that demands specific medical treatment. 
EtiologY and Characteristics 
Hyperkinesis is still misunderstood despite tremen­
dOUB volumes of basic research and clinical observations. 
Theories of causality run the gaaut of the imagination. 
Stephenson touches upon many factors in hyperkinesis 
causality, for example: as an inherited characteristic; 
physical anomalies; subno~al values of serotonin; lead; 
magnesium; low blood glucose concentrations; smoking during 
14pregnancy; a psychiatric disorder, and more. For these 
myriad of causes for hyperactivity, she says this, If . . . 
have become increasingly disenchanted with the role of 
stimulant drugs and now rarely suggest them. ,,15 
Ney has proposed, for purposes of his study, four 
categories of children considered hyperactive with regard 
to their etiology. They are: 
1. Genetic (constitutional)--Children who were 
hyperactive from a very early age but where the pregnancy for 
the mother and the perinatal events for the child were normal. 
l4Stephenson, "The Hyperkinetic Child: Some 
Misleading Assumptions," p. 768. 
9
 
2. Behavioral (conditioned)--hyperactive children 
whose parents were responding with attention selectively 
to their active distracting behavior. 
3. Minimal Brain Dysfunction (chemical)--children 
with early and continuous hyperactivity and histories of 
abnormal pregnancies or perinatal events. 
4. Reactive (chaotic)--children from home environ­
menta in which there was little agreement on discipline 
where there was considerable marital tu~oil.l6 
or 
Walker suggests that hyperactivity may stem from a 
subtle brain dysfunction, and to ft ••• look for mal­
functioning in the neurophysiological processes related to 
the brain."l7 Stephenson adds to this theory by suggest­
ing that hyperkinesis is either caused by or related to mini­
mal cerebral dysfunction; the terms used synonymously.18 
There is controversy concerning statistics of in­
cidence of hyperactivity and what symptoms demand the 
psychopharmacologic treatment. These symptoms could possibly 
16philip G. Hey, M.D., "Four Types of Hyperkinesis," 
Canadian Psychiatric Association Journal 19 (1974):544. 
17Sydney Walker III, "Drugging the American Child-­
We're Too Cavalier About Hyperactivity,n Psychology Today 
8 (December 1974):44. 
18Stephenson, "The Hyperkinetic Child: Some Mis­
leading Assumptions, f' p. 764. 
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indicate not a need for medication but an extremely active 
but normal child. These symptoms tend to be the very 
characteristics adults find annoying in children: impul­
sivity, temper tantrums, and short attention spans. 19 
Differences of opinion continue to be debated but opinion 
rests that an inordinate amount of activity is likely to 
cause learning difficulties. 20 
A child whose motor activity is excessive for some­
one his mental age receives the designation of hyperactive. 
A child's hyperactivity is also excessive when people com­
plain about it. Schmitt sees hyperactivity as a symptom, 
not a diagnosis or a syndrome. As he refers to the 
behavior,n ••• the child is more active than the adults 
in his environment think he should be.,,21 He presents 
this child as more active than others but calls it "develop­
mental hyperactivity," because it is not associated with or 
caused by brain damage. Drug management is not suggested 
19E1len Bowman Welsch, "You May Not Know It, But 
You Probably are Deeply into the Potentially Dangerous 
Business of Teaching with Drugs,"" The American School Board 
Journal 161 (February 1974):41. 
20Bryant J. Cratty, "Calming Down and Tuning Up,11 
Active Learning: Games to Enhance Academic Abilities 
lNew York: Prentice Hall, Inc., 1971), p. 14. 
21Barton D. Schmitt, M.D., Harold P. Martin, M.D., 
Gerhard Nellhaus, M.D., Jere Cravens, M.D., Bonnie W. Camp, 
M.D., Ph.D., and Kent Jordan, M.D, "The Hyperactive Child," 
Clinical Pediatrics 12 (March 1973}:154. 
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with this type of child. 22 Wender concludes that "the 
two most characteristic abberations of motor behavior in 
M.B.D. children are an increased level of activity (hence 
the terms •hyperactivity' and 'hyperkinesis') and impaired 
coordination. n23 
Another theory that Browning suggests is that hyper­
activity is due to Central Nervous System (eNS) ~aturity, 
rather than M.B.D. Central Nervous System inhibition in 
this case is directly proportional to eNS arousal. The under-
aroused child is assumed to have insufficient control over 
his motor and sensory functions and exhibits overall rest­
lessness. This immaturity of the nervous system suggests 
a no~al deviation from the mean of development by perhaps 
two or three years younger than their chronological age 
would indicate. 24 
Walker allows that the causes of hyperactivity may 
not be medical but psychiatric or institutional. It may be 
a manifestation of an emotional disturbance in a child 
22Ibid., pp. 154-155.
 
23wender, "The Minimal Brain Dysfunction Syndrome,"
 
p. 46. 
24niane H. Browning, M.D., "Before Giving Drugs for 
Hyperkinesis," Drug Therapy (September 1975):52. 
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who is neurologically intact and developmentally mature. 
It has two basic emotional sources: 
1. The child lacks the desire to inhibit his be­
havior in order to please the adults taking care of him. 
2. Excessive pressure on or in the child to behave 
in an accepted way.25 
An analogy has been made concerning hyperactive ohil­
dren on eNS stimulants and mice fed a chronic diet of in­
organic lead. The lead treated mice responded in the 
same manner as hyperactive children. 26 
Research has been done linking smoking during 
pregnancy as a cause of the hyperkinetic syndrome. 27 
Nutritional deficiencies have been suggested as a primary 
cause of hyperactivity. Walker reports another condition 
as an inability of the child to tolerate and assimilate 
25Walker, "Drugging the American Child--We're Too 
Cavalier about Hyperactivity," p. 46. 
26E• K. Silbergeld and A. M. Goldberg, "Hyper­
activity: A Lead-Induced Behavior Disorder," Environmental 
Health Perspectives 7 (May 1974):231; and E. K. Silbergeld 
and A.M. Goldberg, "Pharmacological and Neurochemical In­
vestigations of Lead-Induced Hyperactivity," Neuropharmaco­
~ (1975):432. 
27R. Denson, M.D., J. L. Nanson, M.A. and M.A. 
McWatters, R.N., "Hyperkinesis and Maternal Smoking,tt 
Canadian Psychiatric Association Journal 20 (April 1975):
186. 
.. \ 
.-!!~ ..•••" ......-,-,-+,>­
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glucose (sugar). He also believes that if the body does 
not receive or use enough calcium, there may appear symptoms 
of hyperactivity.28 
The Druss 
History of Medication 
Research using medication to treat hyperactivity 
began in 1937 when Bradley observed thirty' children on 
Benzedrine drug therapy. The disorders ranged from specific 
learning disabilities to aggressiveness associated with 
epilepsy. He found po,sitive effects for more than the 
majority of children. 29 
One June 29, 1970, the Washington Post first claimed 
that 5 to 10 percent of the 62,000 elementary school chil­
dren tested were treated with "behavior modifying drugs 
to ~prove classroom deportment and increase learning 
potential.,,30 The article was found to be in error, estimat­
ing learning disabilities, not drug usage. The article 
caused a public outcry and concern in dealing with medicated 
children. 
28Walker, "Drugging the American Child--We're Too 
Cavalier About Hyperactivity," p. 44­
29Charles Bradley, "The Behavior of Children Receiving 
Benzedrine,n American Journal of Psychiatry 94 (November 
1937):585. 
30 Grinspooa and Hedblom, "The Treatment of Hyper­
kinetic Children," p. 227. 
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A Congressional Hearing was held on September 29, 
1970, to investigate the extent of government involvement 
in this practice. Testimonies of government officials, in 
particular Lipman of the F.D.A., revealed 150,000 to 200,000 
children on stimulant drugs and the figures moving on the 
.
upsw1ng. 31 
Congressm~n Gallagher who chaired the hearing, 
pointed out that only one study had been done (and then 
only involving sixty-seven cases) to demonstrate the absence 
of hanMful effects. 32 
The panel essentially approved the use of stimulant 
drugs after careful diagnostic study and as part of a 
comprehensive therapeutic program. 
The R.B.W. panel report was effective in quieting 
public debate because (1) it allowed little possibility 
that there may be non-medical causes of hyperkinetic be­
havior, (2) caution was urged in prescribing medication. 33 
31Ibid., pp. 227-228. 
32 Griaspoon and Singer, "Amphetamines in the Treat­
ment of Hyperkinetic Children," p. 517. 
3~essinger, "Ritalin and M.B.D.," p. 7. 
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Only one follow-up study has been undertaken by 
Connors, Bradley, Denhoff and Laufer. Results indicated that 
hyperactive children receiving amphetamines showed a low 
incidence of psychiatric disorders in adolescence. 34 
The drug industry, in particular CIBA (which pro­
duces Ritalin) has done much to promote the use of ampheta­
mines. Hentoff reported in May, 1972, that in a 1971 elBA's 
territorial sales report, a sales executive was urging his 
salesmen to become "more effective pushers. n35 The same 
company instituted a screening program to identify children 
with learning disabilities. Drug salesmen are the appropriate 
people to embark on a procedure for prescribing medication. 
Though teachers have exerted pressure to place 
hyperactive children on stimulants, this responsibility 
had been questioned in 1970 by Selznik, then school system 
superintendent of special education. He believed that 
guidelines and controls were lacking in the area of 
responsible drug administration. 36 
34 Grinspoon and Singer, "Amphetamines in the Treat­
ment of Hyperkinetic Children," p. 517. 
35 Grinspoon and Hedblom, "The Treatment of Hyper­
kinetic Childre~,n p. 229. 
36 Gri.nspool'l and Singer, nAaphetamil'les in the Treat­
ment of Hyperkinetic Children," p. 518 
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A pioneer researcher, Denhoff in 1971, wrote con­
cerning the use of amphetamines for problem children, that 
the physician was writing prescriptions indiscriminately, 
depending on behavior descriptions of a parent or teacher. 37 
The public has not been given much in the way of 
solid scientific fact and the need for policy recommenda­
tiona persists. Entering into the controversy are the 
medical profession, governmental regulatory agencies, and 
educational institutions who collectively are unwilling to 
have their professional prerogatives or bureaucratic 
authority questioned or jeopardized. 38 
While psychiatrists estimate the incidence of hyper­
kinesis at 4 to 10 percent for elementary school children, 
educators estimate a range of 15 to 20 percent. 
"Hyperactivity has become an epidemic in this country. 
Conservative estimates put the number of afflicted at about 
5 percent of all American school children, or almost a 
million and a half youngsters,,,39 cites Walker. He goes on 
37Grinspoon and Hedblom, "The Treatment of Hyper­
kinetic Children," p~ 230. 
38Messinger, "Ritalin and M.B.D.," p. 6. 
39Walker, "Drugging the American Child--We're Too 
Cavalier about Hyperactivity," p. 43. 
i .. 'oIt­
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to say that tr ••• 10 to 15 percent of the students in some 
school districts are taking potentially dangerous drugs by 
prescription from a family doctor, frequently at the urging 
of school authorities. n40 
The impressions of clinicians in various settings 
are that the syndrome constitutes the most common cause of 
chronic behavioral problems in pre-adolescence. 41 
Estimates of an increase in hyperkinesis may be because 
there is an increased awareness of the problem rather than 
an actual increase. Yet parents, educators and professionals 
working with children claim an actual increase in hyper­
kinesis as well as learning difficulties. 42 
Diagnostic Criteria 
The behavior associated with hyperactivity usually 
comes to professional notice when the child begins school. 
In the classroom his distractibility, poor concentration, 
impulsivity, and aggressive behavior make learning difficult 
40Ibid.
 
41Wender, "The Minimal Brain Dysfunction Syndrome,"
 
p. 45. 
42Ben F. Feingold, M.D. "Hyperkinesis and Learning 
Disabilities (H-LD) Linked to the Ingestion of Artificial 
Colors and Flavors," American Medical Association (1974):
4. 
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and cause classroom management problems. 43 These management 
problems and similarly chaotic h~me situations often provide 
the impetus which leads to the initial referral of the 
child to a physician. Referral usually involves a succes­
sion of nonpedagogical professionals removed from the day-
to-day situations posed by those problems of classroom 
management. 
Clinical experience has repeatedly confi~ed that 
nchildren are referred to pediatricians because teachers 
or parents judge that they have a problem, not because of 
oDjective task performance.,,44 
With the n~erous variables involved it becomes 
difficult to make a p~ecise and objective diagnosis. 
Judgments are second hand, colored by parents' needs and 
vary with time and setting.45 Typically, it is the school 
tha~ pushes for a medical or psychiatric evaluation. The 
teacher or guidance counselor gives information to the 
parents, who convey the information to the physician. It 
43Corinne J. Weithorn, Ph.D. and Roslyn Ross, Ph.D., 
"Stimulant Drugs for Hyperactivi~y: Some Additional Dis­
turbing Questions, ft American Journal of OrthopsYchiatrY'''46 
(January 1976):170. 
44Herbert E. Rie, Ph.D., "Hyperactivity in Children," 
American Journal of Diseases in Children 129 (July 1975):783. 
45Messinger, "Ritalin and M.B.D.,lt p. 9. 
19
 
is rare that the physician consults the school personnel 
o_r observes the child f s interaction. When exasperated 
parents or teachers demand drug treatment, the physician is 
caught between the chaos the child is causing at home and 
schoo1, and his own doubts about diagnosis or efficacy of 
treatment. 46 The child may have a diffuse nervous-system 
disorder, or possibly his activity is due to his home 
environment or may even be teacher-induced. 
How objective, accurate, and valid are the criteria 
for "too much activity" or "too little concentration"? 
The ability to focus and maintain attention is a develop­
mental process. Without objective criteria it is not 
readily dete~inable whether the allowable range of 
individual differences has been overreached. 
Generally, it is not the physican's medical examina­
tion that constitutes the primary basis for the diagnosis. 
Instead, it is the reported failure of the child to cope 
with the complex demands of his life situation. This life 
situation may includ'e a number of variables intervening 
between observed hyperactivity and possible dysfunctioning 
of the Central Nervous System. These include the child-
teacher ratio in the classroom, the frustration tolerance 
of the teacher or parent, disorganization in the child's 
home life, and the existence of extraneous agents in the 
atmosphere or food substances. 
46Diane H. Browning,M.D., "Before Giving Drugs for 
Hyperkinesis," p. 9. 
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One must be cognizant of the fact that there is 
probably more confusion in relation to diagnosis and appro­
priate criteria for the use of medication for the treatment 
of hyperkinetic children than there is regarding the 
choice of medication. 47 Many scientific studies on psycho­
pha~acology do not acknowledge the complexity. The 
child's capacity to control activity and sustain attention 
vary with interest, fatigue and a host of influences in 
the physical and social environment. 48 Many physicians do 
not ~ruly appreciate the differential diagnosis of the over­
active child. 
The symptoms may be an expression of basic personality, 
anxiety, subclinical siezure disorders, or true hyper­
kinesis. In only the latter condition stimulants might be 
expected to be beneficial. Yet the physician must decide 
"For which patient to use what drug for how long. Medical 
practice does not pe~it the physician the luxury of defer­
ring decisions until knowledge is certain.,,49 
In this setting, the physician must evaluate any and 
all objective criteria available. If the physician is not 
47Council on Child Health. "Medication for Hyper­
kinetic Children," Pediatrics 55 (April 1975). 
48MeSsinger, "Ritalin and M.B.D."
 
49Eisenberg, "Symposium: Behavior Modification by
 
Drugs. tf 
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intent upon making an independent evaluation, he may be 
easily and excessively influenced by the wishes of the 
parents or by a "school report which lRay be biased by the 
desire to expel, transfer, or medicate a student. 1I50 
Questionnaires reflect the subject diagnostic informa­
tion desired. For example, the questionnaire used by 
Satterfield, Director of the Gateways Hospital Hyper­
kinetic Clinic in Los Angeles " ••• betrays the subjectivity 
and vague judgments which enter into the gathering of 
data: can't sit still, is noisy, has more energy than 
other children, can't last at card games, shows off, and 
51so on.n 
Not only is there a debate distinguishing children 
with M.B.D. and/or hyperactivity from those whose progress 
is strictly the result of influences in their social and 
physical environments, but we then debate who should be 
prescribed and who should not. 
Only a thorough, wide-ranginc and patient exploration of 
all these influences can yield a well-rounded and true 
diagnostic picture of the child. But such care and 
time is rarely devoted to the diagnostic process: the 
diagnosis of M.·B.D. is often made on the basis of a 
single visit to the physician. The physician's medical 
50Messinger, "Ritalin and M.B.D."
 
51Ibid., p. 18.
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bias, moreover, often results in a preoccupation with 
the biological factors to the exclusion of all others. 52 
The facts show clearly that there has been a drama­
tic increase in the use of psychotropic drugs during the 
1960's and that physicians who see children, particularly 
hyperactive children, tend to use psychotropic drugs exten­
sively. Sprague cites a survey by Greenberg and Lipman 
which reported that 91 percent of the physicians surveyed 
who treated hyperactive children prescribed such drugs. 
Sprague also reports that Stephen, in a survey of seven 
hundred pediatricians, psychiatrists, neurologists, and 
general practitioners in the Chicago area found that 2 to 
4 percent of school age children in that area are treated 
with psychotropic drugs for an average duration of nine 
months. 53 
Some may wonder whether drug treatment has any 
justification in the face of the associated hazards. There 
are those who argue that the diagnosis of hyperkinesis is 
an epithet hurled at "nonconforming" or even "creative" 
children. Yet, after extensive consideration, the Third 
WHO Seminar on Psychiatric Diagnosis, attended by experts 
52Ibid. 
53Robert L. Sprague, Ph.D. and E. K. Sleator, M.D., 
"Effects of Psychopharmalogic Agents on Learning Disorders,n 
The Pediatric Clinics of North America 20 (August 1973):720. 
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from more than a score of countries and from different 
schools of psychiatric thought, reached agreeMent upon the 
necessity for this descriptive category. Its chief charac­
teristics were listed as extreme overactivity, distracti­
bility, short attention span, impulsiveness, marked mood 
fluctuations, and regression. 54 
Once labeled and classified, implications for decisions 
are openended. Arnold even implies that the self-fulfilling 
prophecy when applied to the placebo influence of unpredic­
table stimulants reinforces positive expectations. 55 
In addition to other criteria, the physician 
responsible for the care of young children would be greatly 
aided if he could identify minimal brain dysfunction early. 
He could then make greater efforts to be supportive rather 
than critical of the parents and, if necessary, use 
phanB8cotherapy. Huessy refers to Prechtl who has developed 
a fo~ to be filled out shortly after a child's delivery 
which provides an index of risk. Efforts could then be 
made to start the child on medication. "We have used it 
54Leon Eisenberg, M.D., "The Hyperkinetic Child and 
Stimulant Drugs," The New England Journal of Medicine 287 
(July - December 1972). 
55L• Eugene Arnold, M.D., "The Art of Medicating 
Hyperkenitic Children," Clinical Pediatrics 12 (January 1973):
37. 
24
 
successfully with children as young as two and would use it 
at an even younger age."56 
Once the physician has completed his diagnosis and 
recommended treatment, he is faced with the difficulties of 
evaluating the results. 
Once the medication is prescribed, its effects take 
place away from the physician's office. The child is 
returned to the people who Jorigina11y referred him for 
treatment. The effect is evaluated by the referror. 
Werry found teacher ratings to be stable, sensitive, 
and informative; the best source of information for assess­
ing drug effect. 57 This is contrary to evidence given by 
Connors, Eisenberg and Barcai. In another study, it was 
determined that subjective ratings by teachers are likely 
to be highly sensitive to positive expectations of benefit 
to be derived from medication, particularly with rather 
intractable problem children who have not previously 
responded to educational efforts. 58 
56Hans R. Huessy, M.D., "Minimal Brain Dysfunction 
in Children (Hyperkinetic Syndrome): Recognition and Treat­
ment," Drug Therapy 3 (September 1973):59. 
57John S. Werry and Robert L. Sprague, lfMethylphenidate 
in Children--Effect of Dosage," Australian and New Zealand 
Journal of Psychiatry 8 (1974):17. 
58C• Keith Connors, Ph.D., Leon Eisenberg, M.D., 
and Avner Barcai, M.D., "Effect of Dextroamphetamine on 
Children," Archives of General Psychiatry 17 (Oct.ober 1967): 
483. 
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Combining the results obtained from studies of the 
behavior of children at home and the studies of play be­
havior indicates that parents may not be a reliable source 
of information as to effects of psychotropic drugs on the 
behavior of their children. 59 This statement is not meant 
to question the observation of parents in general, but it is 
meant to point out that in many cases the parents are ob­
serving the child under exceptionally difficult circum­
stances as indicated by the following points. 
1.	 It seems likely that st~u1aDt medication influences 
attention mechanisms and that these effects are best 
seen when the child is in a structured situation. 
2.	 Although the data are very limited, our results 
indicate that the effect of methtlphenidate lasts 
only four to five hours. If a single dosage is 
administered in the morning, the effects will prob­
ably be worn off'by the time the child returns home 
after school, thus the parents would Dot see any 
effects of the psychotropic medication. 60 
'verry also found that "parent measures of drug 
effect proved to be somewhat unstable across time."61 
Thus, ftbefore and after" assessments are made by 
individuals whose own tensions, feelings, and attitudes are 
59Sprague andSleator, "Effects of Psychopharmalogic 
Agents on Learning Disorders,n p. 730. 
60Ibid., p.7l9. 
6lwerry and Sprague, ltMethylphenidate in Children-­
Effect of Dosage." 
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al~ered by the behaviors they are judging. It should be 
remembered that there are two aspects to the behavior of 
the hyperactive child: (1) he has difficulty coping, and 
(2) he is difficult to cope with. 62 
In the midst of these difficult diagnostic and 
evaluation problems, the most concise list of considerations 
was presented by Solomons. 
Initiation of Therapy 
The private physician has to decide to initiate 
therapy on the basis of the following three factors: (1) 
the child's history and behavior as presented by the parents; 
(2) his behavior and treatment as viewed by the teacher; 
and (3) findings obtained from the medical examinations. 
Further considerations 
Once the practicioner does arrive at the decision 
to initiate drug therapy, he has other considerations to 
ponder. 
1. Can the parents afford the cost of the drug, 
the necessary supervisory visits, and concomitant blood 
studies? 
62Weithorn and Ross, "Stim.ulant Drugs for Hyper­
activity: Some Additional Disturbing Questions. t1 
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2. Do the parents have the intellectual ability 
and/or common sense to supervise their child's medication? 
3. Are the parents receptive to drug therapy? 
4. Is there marital discord in the family or con­
flict regarding the child's care? 
5. Do the parents need therapy themselves in order 
to change the child-rearing practices or attitudes that 
are the basic cause of the child's deviant activity level 
or behavior? 
6. Is there a delinquent sibling (e.g., drug user) 
in the household? 
7. Many of these drugs are not without side or 
toxic effects even in therapeutic dosage, and constant 
vigilance is necessary. 
8. There is a large placebo effect with some of 
these drugs, reaching 67 percent in the study by Knights 
and Hinton, in which methylphenidate was used. 
9. No scientific evidence exists to prove the 
non-ha~ful effects of long-te~ medication. 
10. Has the physician really delineated the 
problem and made the correct diagnosis? 
11. Does anyone ask the child how "he" feels? The 
child has no alternative in the decision to take medica­
tion. 
12. Would ttbehavior modification" at home or in 
school accomplish the same results without potential 
risks? 
28 
13. How much does the physician contribute to the 
present drug culture by the offhand or injudicious use 
of medication?63 
Pharmacologic Agents 
The use of medication may solve many problems for 
the people involved with the child, simply by labeling the 
child and altering his behavior. Management of these 
children demands: 
• • • tolerance for ambiguity, resistance to premature 
acceptance of definitive and potentially misleading 
conclusions, and restraint in treatment, especially 
when treqtment entails reliance on drugs of uncertain 
benefit, 04 
cautions Rie. 
The clinical syndromes for which stimulants are 
prescribed are motor restlessness, short attention span, 
poor impulse control, learning difficulties, and emotional 
lability. 65 
63Gerald Solomons, "Drug Therapy: Initiation and 
Follow-Up," Annals of New York Academy of Science 205 
(February 28, 1973):335-343. 
6~e, "Hyperactivity in Children," p. 789. 
65Eisenberg, "Symposium: Behavior Modification by 
Drugs - III, ft p. 709. 
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Schain reports a high correlation between use of 
stimulant drugs in children living in socially and economical­
ly disadvantaged areas and hyperactivity.66 These minority 
children may have been enthusiastic about school until they 
were diagnosed and treated. In opposition to this theory, 
Krager points out that wealthier areas reflect more specialized 
and frequent medical care; therefore, they receive medication 
to a greater degree than those less fortUnate. 67 
The attitude of a prescription being the end-all­
be-all solution to the problems of the hyperactive child 
makes everything else superfluous and leads to a dead end 
in the search for further help. 
Activity in children can vary from day to day, situa­
tion to situation, or from time to time within the same 
situation. There can be no disputing the hypothesis of 
differential drug effects depending on the situation observed, 
the raters employed, and the specific scale used. 68 
66Richard J. Schain, M.D., and Carol S. Reynard, M.S., 
nObservations on Effects of a Central Stimulant Drug (Methy­
phenidate) in Children with Hyperactive Behavior," Pediatrics 
55 (May 1975):715. 
67John M. Krager, M.D., M.P.H. and Daniel J. Safer, 
M.D., "Type and Prevalence of Medication Used in the Treat­
ment of Hyperactive Children," The New England Journal of 
Medicine 291 (November 21, 1974}:1120. 
68L. M. Greeberg, M.D., M.A. Deem, Ph.D. and S. 
McMahon, M.D., "Effects of Dextroamphetamine, Chlorapromazine, 
and Hydroxyzine on Behavior and PerfonBance in Hyperactive 
Children," American J. Psychiatry 129 (November 1972):49• 
. ­
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The American Academy of Pediatrics sees three 
problem areas concerning the use of amphetamines for hyper­
active children. They are: (1) the absence of uniform 
agreed upon terminology; (2) variability in methodology 
for evaluation; (3) the absence of standardized requirements 
for precise diagnosis and classification of the symptomatol­
ogy constituting learning impediments. 69 
Grinspoon and Singer discuss the H.E.W. conference 
of 1971 in terms of how the Report of the Conference did 
little but restate the difficulties in diagnosing hyper­
kinesis and stress the lack of research into long term 
effects of stimulants. The most disturbing aspect was how 
the report was used for justifying the existence of hyper­
kinesis and the over-prescription of stimulants in treating 
the condition. The report was later used in ads from drug 
companies as an endorsement of their products. 70 
Grinspoon and Singer suggest that before science 
has had an adequate opportunity to research the use of drugs, 
69Vonder Haar, "Chaining Children with Chemicals," 
p. 16. 
70Grinspoon and Singer, "Amphetamines in the Treat­
ment of Hyperkinetic Children," p. 545 • 
..... :.;-. :: 
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political pressure has been exerted to justify its existence 
as a medically diagnosable entity.71 
Instead of realizing that the diagnosis of hyper­
kinesis is used excessively, and trying to set up special 
educational techniques for the active children, schools are 
using the easiest method available. Unfortunately, it 
is the first approach advised by school personnel instead 
of a last resort for a child whose classroom behavior is 
divergent. 72 If individual differences in children were 
allowable in school, children would not have to be re­
strained by drugs. One mother was warned that her daughter 
would masturbate "with all that energy" if Ritalin treat­
ments were not permitted. 73 
Messinger points out the " ••• powerless position 
of children coupled with their compulsory school attendance 
make the dangers to children of chemical control particularly 
great."74 Because they are required by law to attend for 
7lIbid., p. 539. 
72Stanley Krippner, Robert Silverman, Michael Cavallo, 
and Michael Healy, "A Study of I Hyperkinetic I Children Re­
ceiving Stimulant Drugs," Academic Therapy 8 (Spring 1973):
268. 
73vonder Haar, "Chaining Children with Chemicals," 
p.	 15. 
7'\iessinger, "Ritalin and M.B.D.," p. 2. 
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approximately ten years, they are subject to institutional 
rules and like prisoners, are presumed bad. "Like mental 
patients, their reports on what the authorities do to them 
are suspect, and their opinions are given little credence.,,75 
Children are brought to doctors because their behavior is 
disturbing to adults, not because of the child's felt needs 
or wishes. "And when they feel it necessary, adults can 
control that disturbing behavior with a heavy chemical 
hand. ,,76 
Stimulant drugs are grossly abused in American 
society, as are all drugs. The temporary effects are far 
outweighed by the risk for habituation. nYet physicians 
continue to prescribe them almost indiscriminately, they are 
manufactured in entirely excessive amounts; they circulate 
through an extensive black market," warns Eisenberg. 77 He 
admonishes recent efforts by medical societies to limit drug 
use to legitimate indications as a belated step in the right 
direction. Because drugs are given to children to alter 
their behavior, it is important to measure well-defined 
behaviors you expect to alter. 
75Ibid• 
76Ibid• 
77 Biseaberg, IISymposium: Behavior Modification by 
Drugs - III," p. 714. 
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Krager cites an unusually high figure of 300,000 
,children in elementary schools presently on psychotropic 
medication for school difficulties. 78 He adds that in one 
county, the school nurse distributes medication to 61 percent 
of the children. 
Another statistic cites nearly 2 percent of elementary 
school children receive stimulant medication. 79 Of chil­
dren ages six to twelve, approximately 640,000 were receiving 
hoact 1ve drugs, percent were prescr1 e 1 a 1D. 80psyc · 59 -b d Ret 1­
Perhaps the reasons for the high incidence of 
amphetamines is: (1) the possibility of misdiagnosis; 
(2) lack of investigative effects on long-term risk; and 
(3) lack of nondrug alternatives. 
Once the decision has been reached to initiate drug 
therapy, the behavior itself will determine the choice of 
drug. Also to consider is age and parental reaction 
" ••• to the use of a 'hard drug' such as amphetamine, 
78Krager and Safer, "Type and Prevalence of Medication 
Used in the Treatment of Hyperactive Children," p. 1120. 
79Daniel J. Safer, M.D., and Richard P. Allen, Ph.D., 
"Stimulant Drug Treatment of Hyperactive Adolescents,n 
Diseases of the Nervous System 36 (August 1975):454. 
80Messinger, "Ritalin and M. B.D., "p. 3. 
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compared to their acceptance of a •benign'	 medication, 
81
such as an antihistaaine,n writes Solomons. 
In many instances, trial and error determines the 
appropriate drug. Doctor Wender advocates erring on the side 
of 
• • • over-diagnosis, since doing so will suggest the 
initiation of a therapeutic drug trial. By erring in 
this direction, one may treat a few children for whom 
drug management was unnecessary, but one will treat 
many more children in whom the diagnosis might have been 
missed. 82 
Because tranquilizers are more predictable than 
stimulants, they are relied upon more often by busy physicians. 
They carry risks such as allergic reactions, blood dyscrasia 
and organ toxicity which stimulants do not. Stimulants 
are, therefore, suggested first and tranquilizers kept in 
reserve. 83 
Despite the success of stimulants, Lewis cites a 
20 percent figure for patients who never respond to treat­
ment. Among children with good response, gradual loss of 
81Solomons, "Drug Therapy: Initiation and Follow­
Up,t1 p. 338. 
82wender, "The Minimal Brain Dysfunction Syndrome," 
p. 55. 
83Arnold, "The Art of Medicating Hyperkinetic Chil­
dren," p. 35. 
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control was found in a significant though undefined 
percentage. Mention is also made of the possibility of side 
effects. 84 
Dosage regimen is important, especially the time 
element, so that it will not interfere with sleep, yet 
administered often enough to provide a balanced day. 
Slow release capsules appear to work the best because of 
the time release and the advantage of not having to necessi­
tate the school nurse or administrator in the midday 
medication. 
Side and toxic reactions necessitate either reduc­
tion in dosage or discontinuation. 8S Routine blood 
studies are important as well as frequent family contact 
with the physician. Many physicians accept cases and do 
little in terms of treatment compilations because of the 
lack of time or commitment. 
One principle of dosage administration is to in­
crease the dosage until an optimum treatment response is 
reached or side effects become objectionable. 86 ~funy 
84James A. Lewi~, M.D. and Rosemarie Young, Ph.D., 
ItDeanol and Methylphanidate in Minimal Brain Dysfunction," 
Clinical Pharmacology and Theraputics (January 1975):535. 
8SSolomons, "Drug Therapy: Initiation and Follow­
Up," p. 338. 
86wender, "The Minimal Brain Dysfunction Syndrome,11 
p. 58. 
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children are currently receiving unnecessarily high doses 
and side effects are more common than generally stated. 87 
A single dose of methylphenidate is as effective for 
school day use as is multiple dosage forms of dextroamphe­
tamines. Cost reduction of medication, a simpler schedule 
which eliminates school nurse involvement and a reduction 
88in side effects are reasons stated for single dosage. 
Methylphenidate is the generic name for Ritalin, 
the most commonly prescribed medication for hyperactivity. 
Ritalin and the amphetamines Dexedrine and Benzedrine are 
classified as stimulant drugs. 89 
Ritalin was first introduced by elBA-Geigy Pharmaceu­
tical Company in December, 1955, for adults. In March, 
1961, it was suggested for use to treat children with 
functional behavior problems (FBP). In 1970 the U. S. Food 
and Drug Administration sanctioned its use in treatment 
of M.B.D., but not without controversy. Advertising and 
reports of M.B.D. incidence skyrocketed. Sales of Ritalin 
87werry and Sprague, "Methylphenidate in Children-­
Effect of Dosage,tt p. 17. 
88Safer and Allen, "Single Daily Dose Methylphenidate 
in Hyperactive Children,"pp. 325-327. 
89walker, "Drugging the American Child--We're Too 
Cavalier About Hyperactivity," p. 48. 
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soared to thirty million dollars annually and 80 percent 
of the pediatric stimulant market. 90 
CIBA then transformed the tenm FBP to M.B.D. and used 
them synonymously, rejecting the implications of the term 
"functional" to indicate a nonorganic cause while "brain 
9ldysfunction" suggests an organic cause. Profit and 
marketing considerations obviously overwhelmed pharmacologi­
cal considerations. 
CIBA, the company holding the largest market in drugs 
for the symptoms of M.B.D., presents a lengthy list of non­
specific signs: specific learning disabilities, impulsi­
vity, disorders of memory and thinking, emotional lability, 
a higher than average number of abnormal waking BEG's, 
and so the list continues. 92 One would not be too sur­
prised to find that nearly half the boys in the first 
three grades of an average public school system could be 
considered candidates for the designation of M.B.D. 93 
Vonder Haar observed that teachers and school 
officials assist elBA and Abbott in marketing assistance when 
90Messinger, "Ritalin and M.B.D.," pp. 2-3.
 
9lIbid., p. 4.
 
92Ibid., p. 8.
 
93Ibid . 
they: 
• • • push pills on their pupils with abandon while 
congratulating themselves on their rtscientificn and 
"professional" approach. With such distinguished 
help, the drug companies w~ll continue to promote the 
cure in search of disease. 4 
Ritalin has been described as a "more potent 
hallucinogen per unit of weight than LSD, and can cause 
withdrawal symptoms if taken to excess.,,95 Along with 
amphetamines, Ritalin falls under hard narcotic controls. 
Since 1971 the U. S. Department of Justice's Bureau of 
Narcotics and Dangerous Drugs has levied controls because 
of their potential for abuse. 
Vonder Haar refers to the Physician's Desk Reference 
and notes that Ritalin should be given cautiously to 
emotionally unstable patients, and goes on to list twenty-
two adverse reactions. He is worried and dismayed about 
the ttwholesale drugging of children whom adults find diffi­
n96cult to manage. 
Cott states just as strongly that he: 
• • • deplores the state of affairs in the area of 
learning disabilities which makes the use of pediatric 
neurologists and pediatricians as the primary 
intervention into this ever-increasing condition. 97 
94vonder Haar, "Chaining Children with Chemicals," 
p. 15. 
95Wa1ker, "Drugging the American Chi1d--We're Too 
Cavalier About Hyperactivity," p. 48. 
96Vonder Haar, ItChaining Children with Chemicals," 
p. 15. 
97A11an Cott, "A Reply," Academic Therapy 13 
(November 1977):164. 
'",. 
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Walker believes that stimulants only mask the 
symptoms, not cure them. He states quite strongly, 
In my medical practice I see many hyperactive children. 
have never prescribed stimulants for these patients, 
and I never wil1.98 
He believes the hyperactive child's problem can almost 
always be identified and treated, if every clue is considered. 
Underlying problems could be neurological, psychiatric, 
neuro-chemical or neurophysiological. 99 
An evaluation of measurement of activity before 
and after treatment with methylphenidate revealed that 
patients with the highest levels of motor activity were 
most likely to respond, whereas those with initially lower 
levels of activity were sometimes worsened by the drug. The 
most active patients had the highest number of neurological 
abno~alities and the response to therapy was related to 
100the degree of brain damage. 
98Walker, "Drugging the American Child--\'1e f re Too 
Cavalier About Hyperactivity," p. 43. 
99Ibid• 
lOOGordon Millichap. "Drugs in Management of 
Minimal Brain Dysfunction," Annals of New York Academy of 
Science 205 (February 28, 1973):325. 
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Gitte1man-Klein has shown methylphenidate to cause 
a significant increase in heart rate, to which tolerance 
does not develop. The author concludes that a larger 
· 101dosage than necessary has been g1ven. Aman confirms 
these findings and alerts us to the additional elevation 
102in blood pressure. 
When comparing the effects of this drug and a token 
system in modifying behavior, Christensen found the f911ow­
ing l~itations: (1) the design of the study did not allow 
individual subject's responsiveness to the medication; 
(2) it did not allow for establishment of optimum dosage 
for each subject with possible side effects; (3) an 
absence of the manipulation of medication exclusively; 
(4) results may be l~ited to the specific environment 
and drug variables. His overall findings were that the 
additional use of stimulant medication was superfulous when 
1- S - 103a t k em 1n use.oen syst 
Amphetamines continue to be controversial largely 
because they are drugs of addiction. A depressive 
lOlRachel Gittelman-Klein, Ph.D., "Pharmacology in 
Hyperkinetic Children," Pharmacology Bulletin 10 (October 
1974):31. 
lO~. G. Aman and J. S. Werry, "The Effects of 
Methylphenidate and Haloperidol on the Heart Rate and Blood 
Pressure of Hyperactive Children with Special Reference to 
Time of Action," Psychopha1macologia 43 (1975):167. 
l03Donald E. Christensen, "Effects of Combining 
Methylphenidate and a Classroom Token System in Modifying 
Hyperactive Behavior," American Journal of Mental Deficiency 
80 (Novem.ber 1975):274-275. 
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state follows withdrawal and produces a syndrome resembling 
paran01· d h· h · se 1Z0p ren18. 104 
Although no chronic toxic reactions have been demon­
strated over several year periods of time, they have been 
reported in abusers who use the drug in doses several times 
as	 h · h 10519. 
Children receiving dextroamphetamine in particular 
complain	 of decreased appetite and stomachache, headache, 
· ht 1 · d·· 106 S 1 ·twe1g oss, anorex18, an 1Dsomn1a. 0 omons C1 es 
it as the drug of choice but advises not to use the tenD 
itself to parents and to write the prescription as 
Ilamphetamine sulfate. fl107 
Research has been made in using the electroencephalo­
gram of nocturnal sleep to investigate the effects of 
psychoactive drugs. Feinberg reports slight change in 
waking BEG in response to drugs but in contrast, the noc­
turnal patterns appeared differentially affected by 
l04Irwin Feinberg, M.D., Satosqi Hibi, M.A., Madeleine 
Braun, M.A., Cleve Cavness, George Westerman, M.D., and 
Arthur Small, M.D. "Sleep Amphetamine Effects in M.B.D.S. 
and Normal Subjects," Archives of General Psychiatry 31 
(November 1974):723. 
l05Wender, IlThe Minimal Brain Dysfunction Syndrome," 
p. 58. 
l06Greenberg, Deem, McMahon, "Effects of Dextroampheti­
mines, Chloropromzine, and Hydroxyzine on Behavior and Per­
formance in Hyperactive Children,t1 p. 48. 
l07solomons, "Child Hyperactivity: Diagnosis, 
Treatment," p. 55. 
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different classes of psychoactive drugs. loB The few 
changes exhibited were later REM onset and somewhat more 
intense eye movement activity. 
Another area of concern is that little is known of 
the direct action of drugs on the central nervous system. 
The correspondence between the underlying physiological 
action of the drugs and their indirect behavioral effects 
109remain	 largely theoretical at present.
Despite the widespread misconception that stimulants 
have a paradoxical effect on hyperactive children, 
there really is no evidence that these drugs act dif­
ferently on the central nervous systems of hyperactive 
children than on the central nervous system of anyone 
else, 
· "'-h	 110reports We1~ orn. It has been reported that stimulant 
drugs do not sedate but increase vigilance and persistence 
in hyperactive children, thereby reducing motor activity as 
111 
a by-product. 
lOBFeinberg, et aI, "Sleep Amphetamine Effects in 
M.B.D.S.	 and Normal Subjects," pp. 723-729. 
l09Ibid• 
110Corinae J. Weithorn, Ph.D. and Roslyn Ross, Ph.D. 
"Stimulant Drugs for Hyperactivity: Some Additional Disturing 
Questions," p. 168. 
lllG. Weiss, K. K. Minde, J. S. Werry, V. I. Douglas, 
E. Nemeth, "Studies on the Hyperactive Child-VIII: Five
 
Year Follow-Up,ft Archives of General Psychiatry 24 (May 1971):
 
409. 
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Controlled studies are limited and reports conflict 
as to the type of hyperkinetic child likely to respond 
favorably. Weiss conducted a study over a five year period 
of children on Thorazine for a one to two year period and 
then switched to Mellaril if the original medication was 
not satisfactory. At the follow-up of adolescence, 80 
percent were underachievers and generally difficult in 
school, 70 percent were emotionally immature and had no 
sense of future goals and suffered low self-esteem and 
112feelings of hopelessness. 
The family of antipsychotic drugs are shown to 
diminish attention span and hence learning ability, they 
also do not increase responsivity to socialization. They 
produce a number of unpleasant side effects and occasional 
dangerous idiosyncratic reactions. Their chronic adminis­
tration in adults for long periods of time has been reported 
to produce a pe~anent neurological syndrome, tardive 
· · 113dYSk1neSJ.a. 
This class of drugs is recommended as alternative 
therapies in patients who fail to respond to methylphenidate 
or dextroamphetamine. Side effects of increased sleepiness, 
112Diane H. Browning, M.D., "Before Giving Drugs 
for Hyperkinesis," Drug Therapy (September 1975):49. 
113wender, "The Minima1 Brain Dysfunction Syndrome," 
p. 58. 
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appetite and weight have been reported with the use of 
chlorpromazine. In addition, symptoms of gastrointestinal 
disturbance were cited. 114 
Mellaril (thioridazine) has been recommended for 
aggressive and destructive manifestations of behavior pre­
sent with hyperactivity. Side effects of blurring vision, 
dryness of mouth, nausea, vomiting and even seizure 
activity being reported. 115 
Thorazine (chlorpromazine) usually is used for 
hyperactive, mentally retarded children, particularly 
where temper tantrums, boisterousness and destructive 
behavior are evident. Side effects are drowsiness, dry 
mouth, nasal congestion, photosensitivity of the skin, 
jaundice, and agranulocytosis. Seizures may be percipi­
t a t e d by th18 rug 1n persons W1v no pr10r 18 ory. · d· · "'-h · h· t 116 
Benardryl (diphenhydramine) is particularly effec­
tive in children under the age of ten. It is an 
l14Greenberg et al., "Effects of Destroamphetamine, 
Chloropromzine, and Hydroxyzine on Behavior and Performance 
in Hyperactive Children," p. 48. 
115solomons, "Child Hyperactivity: Diagnosis, 
Treatment, tf p. 56. 
l16Ibid., and Greenberg, et al. "Effects of Dextroam­
phetamine, Chloropromzine, and Hydroxyzine on Behavior and 
Performance in Hyperactive Children," pp. 45-50. 
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antihistamine and of low toxicity. It can be used as a 
sedative and to reduce anxiety.117 
Children often become tolerant to tricyclic anti­
depressants, mentioned by Wender as not being as effective 
as stimulant drugs. He adds that no long-tenB chronic 
toxological studies have been perfonBed for either children 
or adults. lIS 
Millichap reports that barbituates such as phenobar­
bital are "contraindicated because they usually exacerbate 
hyperactivity.u l19 This statement correlates with the 
findings of Worrell who further explains that phenobarbital 
may cause personality adjustmen~s, changing the child from 
a pleasant, hyperactive child to one who is obstinate, 
120irritable and prone to tantrums. 
Stimulant drug treatment for hyperactive teenagers 
has also increased. Opponents critical of this procedure 
base their objections on the following: (1) stimulants 
can potentially be abused by hyperactive teenagers; (2) 
117Solomons, "Child Hyperactivity: Diagnosis, Treat­
ment,"	 p. 56. 
118lvender, "The Minimal Brain Dysfunction Syndrome, n 
p. 58. 
119Millichap, "Drugs in Management of Minimal Brain 
Dysfunction," p. 321. 
120James B. Worrell, M.D. and William E. Bell, M.D., 
"Management of Hyperactive Behavior in Children,ft Northwest 
Medicine 70 (January 1971):44. 
,"6 ; 
r,' 
." 
46
 
stimulants are no longer necessary by the time the child 
reaches thirteen; (3) hyperactives as a rule do not respond 
beneficially to stimulants in their teens; (4) stimulants 
no longer produce a paradoxical effect; (5) stimulants may 
suppress growth more detrimentally in the teens. 121 
It has even been suggested that the childts relatives 
or friends may abuse his supply of stimulants. If no other 
method of control is available, another medication is 
· d 122a dV1se • 
Browning suggests that: 
• • • many children are notoriously neglectful in taking 
their own medication, and there are scattered reports 
of children selling or giving their medications to 
schoolmasters, which cause teachers to be apprehensive 
about children bringing any medication to school. 123 
The question of addiction to amphetamine treatment 
especially must be explored further. If the child is not 
physiologically addicted, the child may be psychologically 
inclined to resort to chemicals as an escape from real 
world pressures. The approximately twenty year period 
seems an excessive amount of time to be inf1uenced by 
drug usage, especially when many of those were during 
12lSafer and Allen, "Stimulant Drug Treatment of 
Hyperactive Adolescents." 
122Arnold, ttThe Art of Medicating Hyperkinetic 
Children," pp. 35-36. 
123Browning, "Before Giving Drugs for Hyperkinesis," 
p. 52. 
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formative years. Personality, perception and interactions 
with reality were developed under drugs. Vonder Haar speaks 
of: 
• • • the daily consumption of amphetamine-like medicines 
embalms the personality, preserving the individual from 
the effects of profound happiness or sorrow, from the 
satisfaction of achievement, and from other feelings, 
relationships and events that affect human beings. The 
pickling of young patients, a sort of final solution, 
deprives the patient of essential aspects of his 
humanity. 124 
Abuse of drugs has been explained away as the 
failure of a few doctors to properly diagnose and treat 
their patients. In actuality of practice, the drug 
industry, the medical profession and the educational system 
support the chemical control of children. 
Minde concludes that : 
• • • valid knowledge about drug effects in children 
remains today the Cinderella of research in psycho­
pha~acology. The reasons for this neglect are multiple, 
encompassing conceptual as well as practical problems 
besetting the investigator. 125 
The major problem as M1nde sees it is the confounding 
of children and adults. Physicians and psychologists are 
mentioned as unreliable evaluators of drug effects. Drugs 
are tested in children without using any theoretical 
124vonder Haar, "Chaining Children with Chemicals," 
p. 16. 
125Klaus K. Minde, M.D. and Gabrielle C. Weiss, M.D., 
uThe Assessment of Drug Effects in Children as Compared to 
Adults," Journal of Child Psychology 9 (January 1970):124. 
~~"-""'~-' ""'_"""-..d"_' ,.,. 
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model and comparable diagnostic groups are not 
defined. 
Some of the specific problems in assessing drug 
effects in children are: (1) chi1dren are more responsive 
to change in -their environment; (2) a "seasonal variation" 
in frequency and nature of referrals exist; (3) drug evalua­
tiona are usually carried out on an outpatient basis; 
(4) symptoms vary in response to a particular medication 
depending on intelligence, severity and type of psycho­
pathology of the individual; (5) children respond with more 
individual variation to an identical dose of medication 
(because they are less sensitive to drugs than adults and 
require larger doses per kilogram of weight); (6) age may 
· d 126a ffect responses t 0 psych oact1ve rugs. 
Side Effects 
Physical Effects 
Though it can be said that children's behavior has 
benefited by amphetamines, toxic effects have also been 
reported. Toxic effects include anorexia, insomnia, 
gastrointestional distress, dizziness, fine tremor with 
coldness of the extremities and pallor of the skin. In 
general, treatment is not discontinued, rather dosage or 
126Ibid., pp. 124-128. 
time of administration is adjusted and effects diminish 
as treatment is continued. 127 
Stimulants appear to be the favored treatment for 
hyperkinetic children, with several clinical considerations 
"1 · · .4- • -'-h· useful 128 G •1tt 1man-Kl· wrotLm1~1ng ~e1r ness. e e1n e: 
• • • With very low doses some children develop side 
effects so severe that therapeutic doses cannot be 
reached. In these admittedly rare cases, insomnia 
and appetite reduction with rapid weight loss are usual. 
A more common pattern of stimulant intolerance occurs in 
children who can reach therapeutic doses, but who can­
not be maintained OD them over long periods of time be­
cause the gradual development of side effects, insomnia 
and weight loss, being prominent. In addition, tachycar­
dia and psychotic manifestations have occurred at dosages 
necessary for the alleviation of the children's hyper­
aetivity.l29 
It must be stated that all children will not improve 
on medication. According to Bradley, some symptoms may 
even become more severe. Eleven percent out of two hundred 
seventy-five children treated with Benzedrine showed an 
increase of all the hyperkinetic symptoms that originally 
brought them to the attention of a physician. These 
127Grinspoon and Singer, "Amphetamine in the Treat­
ment of Hyperkinetic Children," p. 537. 
l28a• Gittelman-Klein, "Pilot Clinical Trial of 
Imipramine on Hyperkinetic Children," Clinical Use of Stimu­
lant Drugs in Children (March 1972):192. 
129Ibid• 
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symptoms were agitation, anxiety and tension. 130 
A few dramatically adversive reactions have occurred 
as a result of amphetamine administration. Conditions such 
as amphetamine-induced dyskinesia and a case of amphetamine­
induced psychosis in an eight year old hyperkinetic boy.131 
A study delving further into the area of weight 
loss of children taking dextroamphetamines showed suppres­
sion of weight in relation to the norm. Nine children 
having been on stimulants for two or more years were com­
pared with seven children who had been referred but never 
treated. Measures of height and weight were compared and 
it was discovered that eight of the nine in the stimulant 
group showed less annual weight gain than expected in rela­
tion to recorded baseline weight before medication was 
given. In the second and third ensuing years, seven of the 
nine continued their weight loss. Five of the nine showed 
a decrease in height which correlated directly with the 
weight suppression of the control group.13 2 
130Charles Bradley, "Benzedrine and Dexedrine in 
the Treatment of Children's Behavior Disorders," Pediatrics 
5 (January 1950):32. 
l3lS • Levy, TIThe Hyperkinetic Child: A Forgotten 
Entity, Its Diagnosis and Treatment," International Journal 
of Neuropsychiatry 2 (August 1966):330-336. 
132Daniel Safer, Richard Allen, and Evelyn Barr, 
:Depression of Growth in Hyperactive Children on St~ulant 
Drugs," New England Journal of Medicine 287 (July - December 
1972):192-201. 
51 
In another set of data by Safer, concerning twenty 
hyperactive children on ten to fifteen mg. dextroamphetamine 
or twenty to forty mg. methylphenidate daily for the 
nine months of the school year, seven of the children re­
ceived stimulants over the summer months, thirteen did not. 
Over their nine months, weight gain was less than normal, 
though lower dosage appeared to have less effect on sup­
pression of weight gain. Once the children were taken off 
stimulant for the summer months, they exceeded normal weight 
gain, yet did not compensate for the previous nine months 
suppression. 133 Safer and Barr go on to make several 
qualifications based on their observation that height and 
weight impai~ent was greatly affected by long-term use of 
stimulant drugs: when possible, do not administer over 
summer or vacation periods or weekends; further studies 
should be done to check height; weight and height recordings 
should be done by school nurse; and studies should be done 
to verify and replicate these findings. 134 
Safer and Barr suggest a "rebound phenomenon" 135 
has taken place to account for the abno~ally high weight 
133Ibid., p. 191-201. 
134Ibid• 
135Ibid., p. 219. 
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gain during a summer of medication. This substantial 
summer weight gain did not compensate entirely for the 
reduced weight gain during the previous nine months. 
There appears to be no tolerance to this suppression 
though it develops to the initial loss, children may ex­
perience once medication is begun. The authors state the 
effect on weight gain is secondary to suppression of appetite. 
Half of the children in their study ate less than half of 
their meals. Results seem to indicate also that the less 
stimulant medication the hyperactive child recieves, the 
less likely growth is ~o be suppressed. 136 
A significant gain in height occurs following the 
discontinuation of stimulant drugs. It does not 
simply return to no~al when medication is stopped, it 
exceeds expected levels. Therefore, growth rebound is 
proportional ~o growth suppression. 137 
In severe cases of hyperactivity complicated by 
aggressiveness and impulsive behavior, thioriclazine 
Her (Mellaril) given alone or with a stimulant has an 
effect of weight gain; an effect "useful in counteracting 
the anorexic effect of stimulants," claims Peters. 
136Daniel Safer, M.D., Richard Allen, Ph.D. and Evelyn 
Barr, R.N. "Growth Rebound after Termination of Stimulant Drugs," 
The Journal of Pediatrics 86 (January 1975):115. 
137Ibid., p. 116. 
138John E. Peters, M.D., lfMinimal Brain Dysfunc~ion 
in Children, n ~ (July 1974) :122-123. 
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Another report of clinical trials spanned one week 
to a four year duration. Twelve to 14 percent reported 
anorexia as the most troublesome effect with amphetamines, 
along with complaints of stomach pain, irritability and 
· .1nsomnJ.a. 139 
Kornetsky studied the effect of amphetamine diphenyl­
hydantoin and phenobarbital on BEG and behavior problems 
of hyperactivity, impulsiveness, and destructiveness. He 
found one of the earliest showing of a dissociation be­
tween behavior and the electronencephalogram.140 Yet 
this measure is used to indicate M.B.D. 
Insomnia has been reported as a major side effect 
of drug treatment, ending somewhat at the age of eleven 
or twelve. 14l "Gastrointestinal cramps are probably the 
most distressing side effect, n claims Arnold, and !'when 
139Millichap, "Drugs in Management of Hyperkinetic 
and Perpetually Handicapped Children," p. 1529. 
140Conan Kornetsky, "Psychoactive Dru~s in the Imma­
ture Organism," Psychopharmacologia 17 (1970}:12l-122. 
141Report of the Conference on the Use of Stimulant 
Drugs in the Treatment of Behaviorally Disturbed School 
Children (January 11 - 12, 1971), p. 5. 
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they occur, often lead to loss of patient cooperation. n142 
Abdominal discomfort has also been reported with methyl­
phenidate as well as a weight 10ss.143 Of special 
interest was that three children manifested persistent 
tachycardia while under the influence of the drug. One 
child revealed an elevation of blood pressure. 
Page found these startling findings: a total of 
469 side effects were recorded in his groups of study, 
particularly insomnia and anorexia while on pemoline. 
Forty-one percent complained during the first week and 
75 percent during the first three weeks. 144 
Side effects appear to be well known145 and common­
place. Physicians must weigh the possibility of growth 
rate suppression against possible advantages. Tolerance 
142Arnold, "The Art of Medicating Hyperkinetic 
Children, n p. 40. 
143Richard J. Schain, M.D. and Carol L. Reynard, M.S., 
nObservations on Effects of a Central Stimulant Drug 
(Methyphenidate) in Children with Hyperactive Behavior," 
Pediatrics 55 (May 1975):713. 
144John G. Page, M.D., F.A.A.P., Robert S. Janicki, M.D., 
Joel E. Bernstein, M.D., Charles F. Curran, Ph.D., and Frank A. 
~chelli, M.S. "Pemoline (Cylert) in the Treatment of Child­
hood Hyperkinesis," Journal of Learning Disabilities 7 
(October 1974):46-47. 
145Eisenberg, "Symposium--Behavior Modification By 
Durgs--III," p. 711. 
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to the	 anorexogenic effects limit the usefulness of these 
146
agents. 
In a study by Gittleman-Klein concerning the use 
of Impramine in hyperactive children it was shown that ten 
of twelve children exhibited side effects ranging from 
mild to severe. They included dry mouth (5/12); difficulty 
falling asleep (3/12); appetite decrease (2/12); blurred 
vision (2/12); drowsiness (2/12); and headaches (2/12). 
Conclusions were that this agent has greater numbers of 
side effects but less acute or severe than stimulants. 
It should be kept in mind that there exist groups 
of hyperkinetic individuals who do not respond to stimu­
lants. Gittelman-Klein put this number at 15 to 20 per­
cent that cannot be differentiated from the other hyper­
kinetic children. 147 
Drug therapy should be initiated with the mildest 
drug which may be effective. 148 Children rarely report 
146Arnold, "The Art of Medicating Hyperkinetic 
Children, tt p. 40. 
147Gittelman-Klein, "Pilot Clinical Trial of Imipra­
mine in Hyperkinetic Children," p. 198. 
148Ibid., p. 192. 
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symptoms so the parent, teacher or physician should observe 
closely for side effects. 149 
Mention is made by Arnold of cardiovascular dis­
"turbances or he suggests there are ttunpublished suspicions 
that occasional idiosyncratic individuals may suffer such 
n150symptoms. These should be checked for future practice 
to moniter pulse and blood pressure. 
"Tactile hallucinations (e.g. 'skin crawling') 
or tics warrant a reduction or discontinuance of stimulant 
therapy,,,1 51 states Arnold. He also suggests that when a 
stimulant is effective but rich in side effects, a different 
type of drug should be sUbstituted. 152 A small percentage 
of children showed a symptom increase on stimulants at a 
low dosage after a few days. 
Fish concurs with previous authors' evidence of 
subjective discomfort and frequent anorexia with weight 
loss in doses over 15 mg. per day.153 
l49Barbara Fish, M.D., "Drug Use in Psychiatric Dis­
orders	 of Children, tt American Journal of Psychiatry 124 
(January 1968):35. 
l50Arnold, "The Art of Medicating Hyperkinetic 
Children," p. 41. 
151Ibid . 
152peters, "Minimal Brain Dysfunction in Children,11 
p.	 123. . 
153F · 18h , "Drug Use in Psychiatric Disorders of Chil­
dren, n p. 33. 
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Once the drug has taken effect, Solomons recommends 
an appointment with parents to explain and alert for ensuing 
loss of appetite, interference with sleep and an ex­
tremely pale and sallow facial appearance. He refers 
to dark circles under the eyes and facial appearance as 
the Itpanda syndrome. ttl54 
Toxic reactions were reported in amphetamine users 
during heavy doses. Brown reviews literature related to the 
drug Impramine when used for hyperactive behavior disorders 
and finds that there has been a link with the development 
of seizures. It was suggested that it may be due to the 
high dosage prescribed and further studies should take 
place to investigate why it is prescribed in such fashion. 155 
Wender wrote of these unpleasant side effects that 
antipsychotic drugs produce: 
• • • occasional dangerous idiosyncratic reactions; 
their chronic administration in adults for long periods 
of time has been reported to produce a perma&ent 
neurological syndrome, tardive dyskinesia. 1S 
154solomons, "Child Hyperactivity: Diagnosis, 
Treatment," p. 55. 
155David Brown, M.D., Bertrand G. Winsberg, M.D., 
Irv Bialer, Ph.D., Mark, Press, M.D., 'tImipraDline Therapy 
and Seizures: Three Children Treated for Hyperactive Be­
havior Disorders,tt The American Journal of Psychiatry 130 
(February 1973):210-212. 
156wender, "The Minimal Brain Dysfunction Syndrome,1l 
p. 58. 
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Greenberg, Deem and McMahon discovered an unexpected 
finding in increased depression in children treated with 
dextroamphetamine. Many families need counselling with 
their response to the childts behavioral problems as they 
often do not welcome changes in the child's personality. 
He may become less active at the expense of becoming a family 
scapegoat, or a sibling or marital problem. 157 
It has been suggested that depression is a factor 
leading to hyperactivity. These models seem to hold for the 
agitated depressive and the manic-depressive. Only a small 
number of hyperactive children exhibited depression during 
final visits to the pediatrician because here was the one 
place they experienced acceptance, understanding and 
158gratification of their dependency needs. 
Clinicians must exercise caution in prescribing 
psychostimulants such as dextroamphetamine for treatment 
of hyperactive children. The drug may influence personality 
organization and children may have primary or secondary 
emotional disorders. 
Frequent reassessment of these children for which 
integration of personality seems tenuous is recommended. 
Ritalin is implicated in disturbances; the cause 
I 57Greenberg, et aI, ItEffects of Dextroamphetamine, 
Chloropromazine, and Hydroxyzine on Behavior and Performance 
in Hyperactive Children,tt p. 48. 
158Ibid• 
59
 
159suggested	 to be disorganization of thought process.
On long-te~ effects, Wender states that the 
difficulties may not subsist at adolescence but carryover 
into adult years and "in some instances, for the duration 
of life. It is entirely possible that some individuals 
may well require pharmacological treatment for the rest 
of their lives. 1I160 Yet he concludes that these conditions 
have been temporary, since the underlying biological problem 
continues to exist after drugs are discontinued. In such 
instances, "therapy may be permanently suppressive 
although not curative.,,161 
Long term effect is difficult to evaluate because 
of natural growth and development. Investigations are 
important to document drug effect on functions of intelli­
gence and developm~nt of impulse controls which do not 
162
change after drug therapy. Setting up a pattern of 
behaviors occurring at particular developmental periods may 
prove helpful in charting change. Eisenberg comments, 
159Greenberg, et aI, tlSide Effects of Dextroamphetamine, 
Therapy of Hyperactive Children," p. 109. 
160Wender, uThe Minimal Brain Dysfunction Syndrome," 
p.	 60. 161 
Ibid., p. 61. 
I 62Minde, liThe Assessment of Drug Effects in Children 
as Compared to Adults," pp. 129-130. 
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The age related decrease in the most obvious symptoms 
(the restlessness and the distractability) have led to 
premature optimism about the fate of the learning probli~s 
and the behavior disorder associated with the syndrome. 3 
There has been repeated demonstration of a failure 
of transfer of learning between drug and non-drug states. 
Sprague claims there seems to be ft ••• more differential 
forgetting when learning occurred 'on drugs,' suggesting, 
perh aps, an 1n· t erf erence W1· th th·e memory mech··an1sm." 164 
Commenting on childhood drug use as a predisposition 
to adolescent addition, Browning states that ft ••• pro­
longed or indiscriminate use of stimulant drugs in children 
is harzardousFl65 Results of overprescription when stimu­
lant drugs first became popular are failures among children 
who have been on these.drugs for years. She goes on to say 
that the ­
• • • tragedy of these cases is that more often than
 
not, drugs are viewed as a panacea and the child's
 
emotional problems were neglected. 166
 
1 63Eisenberg, "Symposium: Behavior Modification 
by Drugs-III,tr p. 709. 
164Robert L. Sprague, Ph.D., Kenneth R. Barnes, B.A. 
and John S. Werry, M.B., "Methylphenidate and Thioridazine: 
Learning, Reaction Time, Activity and Classroom Behavior 
in Disturbed Children,tt American Journal of Orthopsychiatry 
40 (July 1970):627. 
1 65Browning, "Before Giving Drugs for Hyperkinesis," 
p.	 42. 
l66Ibid• 
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Emotional Effects 
Parents, teachers and peers may contribute to poor 
self-esteem by labeling the child as defective. The 
emotional repercussions to these side effects are myriad. 
A psychological dependence of sorts may grow from a wish for 
the child "to be good" and parents may be unconsciously 
supportive. Schools may carry this further by necessitating 
a trip to the prfncipa11s office to take medication. 
The child may conclude he has no inner controls, 
the pills control good behavior. Browning believes that 
drugs, as a simple solution, foster attitudes that allow 
underlying emotional problems to go unrecognized and un­
attended. 167 
Bosco feels that attitudes and beliefs of other 
individuals significant to the child are important 
factors in drug treatment. These interactions may compli­
cate or enhance treatment, depending upon the attitude 
· de ad 1 168o f these 1n 1V1 ua s. 
In 1971 the U. S. Department of H.E.W. met concerning 
the use of stimulant drugs in the treatment of behaviorally 
167Browning, "Before Giving Drugs for Hyperkinesis," 
p. 52. 
168James Bosco, "Behavior Modification Drugs and the 
Schools: The Case of Ritalin," Phi Delta Kappan 56 
(March 1975):490. 
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disturbed school children. Concern was expressed about 
the child being stigmatized as flstupid," an tJemotional 
169
cripple, n or a n drugtaker. n It set up conditions 
under which drugs should be administered to children. 
Complaints about a hyperactive child's overactivity 
and short attention span stem mainly from the home and 
school. Observations closely agree that the children 
may inhibit their behavior during time spent with the 
physician. 170 A brief one-to-one setting is seldom as 
threatening as the larger family or group situation. 
Children may not be able to describe changes in their 8ub­
jective feelings due to drug effects. A feeling of sadness 
and severe hopelessness may accompany the use of drugs. 
This change can be observed in the child's natural environ­
171
ment and from the child himself. 
Side effects, namely weepiness, excessive preoccupa­
tion with details, irritability, agitation, and dyskinesia 
l69"Report of the Conference on the Use of Stimulant 
Drugs in the Treatment of Behaviorally Disturbed Young 
School Children." 
l70Minde, liThe Assessment of Drug Effects in Children 
as Compared to Adults," p. 129. 
171Ibid• 
........ .
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172have been documented. One author, Schain, noted a 
"personality disturbance characterized by withdrawal, apathy, 
lethargy and other evidences of depression. ttl73 The effect 
occurred in all cases receiving low doses of the drug and 
prompt ~provement was evidenced upon withdrawal of the 
drug. He recommends physicians be aware of these depressive 
reactions and terminate medication promptly when behaviors 
are noted. 
Rie sees the depressed, drugged children as wearing 
a: 
• • • more or less affectless, humorless, and apathetic 
demeanor that made it possible to identify correctly 
every child who was meficated in spite of a double­
blind research method. 74 
Subdued behavior may be reflecting not gross body 
movement and activity level but the way activity is organiz­
ed in relation to the social demands of a situation. Medi­
cated subjects often expend the same amount of energy 
previous to medication but channel energies into more socially 
acceptable activities, so they therefore appear subdued. 175 
172peters, "Minimal Brain Dysfunction in Children," 
p. 123 and Fish, "Drug Use in Psychiatric Disorde~rs of Chil­
dren," p. 34. 
173Schain and Reynard, "Observations on Effects of 
a Central Stimulant Drug (Methyphenidate) in Children with 
Hyperactive Behavior,n p. 714. 
174Rie , "Hyperactivity in Children," p. 788. 
175Connors, et aI, ttEffect of Destroamphetamine on 
Children. n 
....-10•• 1 •• 
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Eisenberg sets forth three circumstances where 
drug usage would be inappropriate in dealing with the over­
active and distractable child: (1) the child who exhibits 
intense anxiety in the midst of grossly disorganized family 
life; (2) the hypoglycemic child who has no regular break­
fast and is malnourished. He exhibits fidgetiness and the 
inability to concentrate; (3) the third concerns the 
"character of the classroom". If overcrowding, teacher 
incompetency or poor facility contribute to chaotic 
activity in a classroom, the indiscriminate use of stimulant 
drugs would be unjustified. 176 
Though depression, temporary whininess and sensi­
tivity have been observed in children on drugs, Arnold 
feels these are not sufficient reason for discontinuing 
medication, in fact, it ft ••• may be a confirmation that 
the ri.ght medication has been found. lll77 
Ambrosino and DeFonte studied the effects of a 
psycho-educational approach to the behavior problems of 
children other than the administration of dexedrine. They 
attempted to deal with the child's mounting anxiety as he 
suffered with eroded learning skills. They saw the child 
l76Eisenberg, "Symposium: Behavior Modification by 
Drugs--III. The Clinical Use of Stimulant Drugs in Children. n 
p.	 712. 
l77Salvatore V. Ambrosino, M.D., and Teresa De Fonte, 
M.A. ftA Psychoeducationa1 Study of the Hyperkinetic Syndrome,n 
p. 207. 
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struggling with increased social isolation and loss of 
self-esteem as a result. They believed that "psychoeduca­
tional treatment requires an intense interdisciplinary 
approach; only in this way can the child l s ego-functioning 
and self-concept be preserved and enriched.«178 
Messinger attributes dysfunction to impai~ent 
within the organism. His view is that hyperactive children 
fail to adapt to the environment. Causes may stem from 
hunger, psychological stress in the home or school, over­
crowded classrooms and unrealistic standards of 1earning. 179 
To focus on inherent pathology as the label M.B.D. 
does, detracts from environmental contributions to the 
problem, namely oppression of these children by the school 
system. The label itself connotes a victim to blame. 
Messinger suggests that medicine and psychiatry look at 
the social causes of disease and disability and use social 
as well as medical controls. He states: 
I submit that the epidemic of minimal brain dysfunction 
that the medical profession claims afflicts hundreds 
of thousands of American school children may similarly 
be a warning of a di~turbance in the development of our 
people and society.l 0 
178Ibid., p. 212. 
179Messinger, "Ritalin and M.B.D." p. 19. 
180Ibid• 
.. .~ 
66
 
The Medical Letter describes adverse effects such as 
abdominal pain, restlessness and palpitations. Depression, 
mood changes, hallucination or psychosis have been reported 
with some children taking stimulants, as psychotic symptoms 
have been seen in adults following long-term misuse of pem­
1 - 181o 1ne. 
Concern is also focused on drugs which produce no 
improvement or intensify symptoms. Lethargy or certain 
disorders such as anxiety reactions may show symptoms similar 
t o h yperact 1V1 y, ye me 1ca 10n 18 con ra1n 1ca e •· at t d· t· · t· d- t d 182 
The problem inherent with children's symptoms manifests 
itself by more rapid changes than those of adults. 183 
Morrison reports use of antidepressants in the 
"lifelong nature of the impulse disorder of hyperactive 
children.,,184 A depressive reaction in one out of three 
l8lThe Medical Letter on Drugs and Therap~ (New Rochelle, 
New York: The Medical Letter, Inc., January 197). 
l82James R. Morrison and Kenneth Minkoff, "Explosive 
Personality as a Sequel to the Hyperactive-Child Syndrome," 
Comprehensive Psychiatry 16 (July/August 1975):347. 
l83weithorn and Ross, "Stimulant Drugs for Hyper­
activity: Some Additional Disturbing Questions,n p. 168. 
l84Fish, "Drug Use in Psychiatric Disorders of 
Children," p. 32. 
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patients indicated ft ••• that a personality disorder 
does not simply represent a tmasked depression t .,,185 
Persistence of irritability and behaviorial outbursts con­
tinued a year after treatment raising a question as to 
effectiveness of prolonged or life-long drug treatment. 
Swwary 
Although long-term effects are serious, there 
exists little documentation of this. The physical effects 
are somewhat easier to measure, whereas emotional effects 
are seen largely through observation. Measures of academic 
progress in reference to long-term drug usage is imperative 
also. 
~. 
CHAPTER III 
S~iARY AND CONCLUSIONS 
Summary 
A review of the literature regarding the treatment 
of the hyperactive child makes evident the controversial 
nature of the use of drugs as a method of treatment. This 
controversy is deeply embedded in every aspect of the topic. 
It begins with the definition of hyperactivity. 
We find hyperactivity defined in vague, highly subjective 
terms. The criteria under which a child is diagnosed to 
be hyperactive are almost entirely of a subjective nature 
and the interpretation of these criteria vary widely. The 
physician is often influenced by the input of parents and 
teachers offering a ttmedical ft solution to the problems 
caused by the child in the home or classroom. However, 
at what point does the variation from t1normal" child 
activity become great enough to be termed nhyperactivitytt? 
If an objectively determined definition of hyper­
activity were available, the next step in prescribing 
treatment would be a determination of the etiology of the 
problem. Here, too, controversy arises. Is the problem 
caused by "minimal brain dysfunction" or is it the result 
of the child's environment? In either case, does the use of 
68 
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drugs correct the problem or merely mask the symptoms? 
It is difficult to determine whether the drug treatment 
is beneficial to the child or whether such treatment pro­
vides primary benefits to the parents or teachers as a 
result of the diminished tendencies of the child to be 
disrupting in the home and classroom. 
Once the physician has decided to treat a child 
with drugs, he must next decide which drug to prescribe. 
This decision may be biased by the extensive marketing 
campaigns of companies such as elBA, which has promoted 
its product, Ritalin, to such an extent that its usage 
has tendencies of a panacea. 
Evaluation of drug treatment is influenced sub­
stantially by the parents and teachers who initially refer­
red the child for treatment. These evaluations, by 
parents and teachers are highly subjective in nature 
and may be biased by the desire of the evaluators to 
minimize the disruptive nature of the child's activity 
while little emphasis is placed on the child's potentially 
improved capabilities to learn in a classroom or home 
environment. 
In light of the controversies concerning definition, 
diagnosis, choice of treatment, and treatment evaluation, 
is there justification for subjecting a child to the 
potential physical, sociological and psychological risks 
involved with drug treatment? 
~ :... 
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Conclusions 
Children are inappropriately treated with drugs 
to achieve behaviorial control without any awareness of 
the individual needs of the child. The problem may not be 
the child but the different definitions, interpretations 
and attitudes of people involved with the child. 
The usual route for this frequent discipline 
problem, usually a boy, is to receive the expedient 
approach, via the brief physician's examination and on to 
the most popular drug, Ritalin. 
To suppress hyperactivity with drugs without dia­
gnosing and correcting the underlying medical or psychologi­
cal problem is akin to putting the cart before the horse. l 
Frequently these children are not excessively active but 
their activity is inappropriate. 
Medical science has a new diagnostic category with 
evidence of responsiveness to st~ulant treatment. Stimu­
lants have become the preferred treatment, even though doctors 
are unsure of the nature and etiology of the disorder. Long-
term effects must be researched further before an epidemic 
of drugged children exists. 
~valker, ttDrugging the American Child--Wefre Too 
Cavalier Abo'ut Hyperactivity," p. 48. 
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